1. Unit startpage
  2. Employees
  3. Hilde Ljones Wetting
Bilde av Ljones Wetting, Hilde
Photo: Bjørn-Kåre Iversen
Bilde av Ljones Wetting, Hilde
Cell Signaling and Targeted Therapy hilde.ljones@uit.no +4777646166 Tromsø

Hilde Ljones Wetting

  • Jeanette Schultz, Kjell H., Kristian, Kjerstin, Eirin Guldsten, Hilde Ljones et al.:
    Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study) – a randomized controlled trial
    BMC Health Services Research 2022 DOI / ARKIV
  • Jeanette Schultz, Kjell H., Kjerstin, Hilde Ljones, Kristian, Beate Hennie :
    Intervention fidelity and process outcomes of the IMMENSE study, a pharmacist-led interdisciplinary intervention to improve medication safety in older hospitalized patients
    Journal of Clinical Pharmacy and Therapeutics 2021 DOI / ARKIV
  • Anup, Henrike, Hanne, Gurjit, Matthias, Hilde Ljones et al.:
    Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38 MAPK-MK2 axis and affects NF-κB-mediated transcription
    Scientific Reports 2020 DOI / ARKIV
  • Rania, Nouf, Kiruthikah, Mark, Bjarne Herold, Hilde Ljones et al.:
    A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration
    Cell Adhesion & Migration 2015 DOI
  • Hilde, Elin Synnøve, Synnøve, Oddveig G, sonja eriksson, elisabeth et al.:
    S100A4 Expression in Xenograft Tumors of human carcinoma cell lines is induced by the tumor microenvironment
    American Journal of Pathology 2011 DOI
  • Elin Synnøve, Hilde, Chandra Sekhar, Ahmad, Oddveig G, Gunbjørg et al.:
    Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive front
    European Journal of Cancer 2011 DOI
  • Elin Synnøve, Hilde, Oddveig G, Sonja Eriksson, Premasany, Reidar et al.:
    Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts
    Virchows Archiv 2010 DOI / ARKIV
  • Renate, Hilde, elisabeth, Thrina, Jan-Olof :
    Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4
    Connective Tissue Research 2008 DOI
  • Kjerstin, Stine-Mari, Hilde Ljones, Jeanette Schultz, Beate Hennie, Scott et al.:
    Workflow of clinical pharmacists leading research at geriatric wards
    2019
  • Tone Ruud, Beate Hennie, Kjell H., Marit, Lars, Hilde Ljones :
    Er det trygt å velge billigere resept-medisiner?
    22. janvier 2015
  • Elin Synnøve, Chandra Sekhar, Hilde Ljones, Oddveig G, sonja eriksson, Gunbjørg et al.:
    Stromal Impact on Tumor Invasiveness and Gelatinolytic Activity at the Invasive Front
    2011
  • Elin Synnøve, Hilde, O, sonja eriksson, Jan-Olof, Gunbjørg et al.:
    Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts
    APMIS - Journal of Pathologiy, Microbiology and Immunology 2010
  • Elin Synnøve, Chandra Sekhar, Hilde, Oddveig G, sonja eriksson, Gunbjørg et al.:
    Organ specific stromal influence on tumor invasiveness and proteolytic activity at the invasive front
    European Journal of Cancer 2010 DOI
  • Hilde, Marianne, Renate, hanne, Jan-Olof, thrina :
    Effects of PGE2 on the Expression of MMP-2 in Osteosarcoma Cells with a High Metastatic Potential (High level of S100A4)
    2006

    • The 50 latest publications is shown on this page. See all publications in Cristin here →

    Publikasjoner utenom Cristin

    Cand.Pharm. avhandling

    Samspillet mellom ekstracellulære matriksproteiner og signalmolekyler i reguleringen av kreftceller utrykk og aktivering av matriks metalloproteinaser (June 2005)

    PhD avhandling

    Oral squamous cell carcinoma - Matrix metalloproteinases, S100A4, and role of tumor-stroma interactions (February 2011)

    Research interests

    Tumorbiologi, invasjon og metastase

    MAP kinaser og intracellulær signalering

    Det metastaseassosierte proteinet S100A4

    Matriks metalloproteinaser

    Turmor-stroma interaksjoner

     

    Teaching

    Undervisning for farmasi og tannpleierstudenter

    FAR-1101 Farmasi grunnemne

    FAR-2202 Farmakologi

    TANN-107  Helhetlig pasienttilnærming, farmakologi

    TANN-114  Voksen- og eldre tannpleie, tannhelse og sykdom,  farmakologi


    Member of research group

    Geriatric Research Group   English content